European Case Law Identifier: | ECLI:EP:BA:2005:T059101.20050316 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 16 March 2005 | ||||||||
Case number: | T 0591/01 | ||||||||
Application number: | 90906651.6 | ||||||||
IPC class: | A61K 31/34 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Stable ascorbic acid compositions | ||||||||
Applicant name: | DUKE UNIVERSITY | ||||||||
Opponent name: | Société anonyme dite: L'OREAL BIODERM, INC. Cellex-C Cosmaceuticals, Inc. |
||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Main request and first auxiliary request: novelty (no) the feature"topic" cannot serve to distinguish the claimed composition from identical compositions used in the state of the art for administration per os Second and third auxiliary requests: inventive step (no)- inclusion of a second, commonly used pharmaceutically accepted carrier into aqueous solutions of a known medicament cannot render the use known per os of such modified solutions inventive |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010591eu1.html
Date retrieved: 17 May 2021